VANCOUVER, Aug. 6, 2019 /CNW/ - WELL Health
Technologies Corp. (TSXV: WELL) (the "Company" or
"WELL"), a company focused on consolidating and modernizing
clinical and digital assets within the primary healthcare sector,
announces, further to its news release dated November 1st, 2018, the Company paid
$96,789 in cash and intends to issue
an aggregate of 14,933 shares in accordance with the acquisition
agreements whereby the Company acquired all of the issued and
outstanding shares of 13 target companies operating an aggregate of
13 Healthcare Clinics in British
Columbia.
The issuance of the shares is subject to the approval of the TSX
Venture Exchange (the "TSXV"). The shares will be subject to
a statutory hold period expiring on the date that is 4 months and
one day after the Payment Date.
WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed
Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL
WELL is a unique company that operates Primary Healthcare
Facilities as well as a significant EMR or Electronic Medical
Records business that supports the digitization of such clinics.
WELL's overarching objective is to empower doctors to provide the
best and most advanced care possible leveraging the latest trends
in digital health. In the last 12 months, WELL physicians served
approximately 600,000 patient visits through its network of 19
medical clinics. WELL is publicly traded on the TSX Venture
Exchange under the symbol WELL.V. WELL was recognized as a TSX
Venture 50 Company in 2018 and 2019.
Forward-Looking Statements
This news release contains forward-looking information that
involves various risks and uncertainties regarding future events.
Such forward-looking information can include without limitation
statements based on current expectations involving a number of
risks and uncertainties and are not guarantees of future
performance of WELL, such as statements that WELL intends to make
the Shares for Debt filing. There are numerous risks and
uncertainties that could cause actual results and WELL's plans and
objectives to differ materially from those expressed in the
forward-looking information, including: (i) adverse market
conditions; or (ii) the TSXV not approving the Shares for Debt
filing. Actual results and future events could differ materially
from those anticipated in such information. These and all
subsequent written and oral forward-looking information are based
on estimates and opinions of management on the dates they are made
and are expressly qualified in their entirety by this notice.
Except as required by law, WELL does not intend to update these
forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
SOURCE WELL Health Technologies Corp.
